NCT03126916 2026-02-27Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 3 Recruiting750 enrolled
NCT00567567 2022-04-28Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk NeuroblastomaChildren's Oncology GroupPhase 3 Completed665 enrolled 26 charts